Bohnen J M, Mustard R A, Oxholm S E, Schouten B D
Department of Surgery, Wellesley Hospital, Toronto, Ontario, Canada.
Arch Surg. 1988 Feb;123(2):225-9. doi: 10.1001/archsurg.1988.01400260113014.
Therapeutic trials for intra-abdominal sepsis require pretreatment stratification; physiologic scoring has been recently proposed for this purpose. We have prospectively tested the validity of one such scoring system, namely, the Acute Physiology and Chronic Health Evaluation (APACHE II). As part of a larger database, we correlated APACHE II scores with mortality in 100 patients hospitalized for generalized peritonitis or abdominal abscess. Use of steroids was recorded because of our suspicion that steroids increase mortality but blunt the physiologic response to sepsis. Thirty-one patients died, including 12 of 19 patients receiving steroids. Stepwise discriminant analysis revealed that the APACHE II score and steroid use were each independently associated with the rate of mortality. We report a prospective validation of pretreatment APACHE II scoring in abdominal sepsis. Steroid use is an independent risk factor.
腹腔内脓毒症的治疗试验需要进行预处理分层;为此最近有人提出了生理评分法。我们前瞻性地检验了一种这样的评分系统,即急性生理学与慢性健康状况评价系统(APACHE II)的有效性。作为一个更大数据库的一部分,我们将100例因弥漫性腹膜炎或腹腔脓肿住院的患者的APACHE II评分与死亡率进行了关联分析。记录了类固醇的使用情况,因为我们怀疑类固醇会增加死亡率,但会削弱对脓毒症的生理反应。31例患者死亡,其中19例接受类固醇治疗的患者中有12例死亡。逐步判别分析显示,APACHE II评分和类固醇的使用均与死亡率独立相关。我们报告了对腹部脓毒症预处理APACHE II评分的前瞻性验证。类固醇的使用是一个独立的危险因素。